Trulieve Cannabis (TRLV) Operating Expenses (2020 - 2026)

Trulieve Cannabis (TRLV) has reported Operating Expenses for 7 consecutive years, with $134.4 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Operating Expenses fell 10.37% year-over-year to $134.4 million; the TTM figure through Mar 2026 stood at $552.1 million (down 13.75% YoY), while the FY2025 annual figure was $567.7 million, down 8.14% from the prior year.
• Operating Expenses came in at $134.4 million for Q1 2026 at Trulieve Cannabis, down from $159.9 million in the prior quarter.
• The five-year high for Operating Expenses was $432.9 million in Q2 2023, with the low at $119.6 million in Q3 2023.
• Average Operating Expenses over 5 years is $163.0 million, with a median of $141.9 million recorded in 2022.
• Across the five-year window, Operating Expenses soared 205.1% in 2023 and slumped 69.53% in 2024, its largest moves.
• Year by year, Operating Expenses stood at $151.9 million in 2022, then decreased by 17.93% to $124.7 million in 2023, then soared by 48.96% to $185.7 million in 2024, then declined by 13.91% to $159.9 million in 2025, then slipped by 15.96% to $134.4 million in 2026.
• According to Business Quant data, Operating Expenses over the past three periods registered $134.4 million, $159.9 million, and $127.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.